CLINICAL_TRIALS
trial_result
· 2021-05-06
Clinical Trial Update: A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Summary
Clinical trial update for nivolumab in advanced non-small cell lung cancer (Phase 1/2) completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-06